These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33986036)

  • 21.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent
    Di Fruscia P; Carbone A; Bottegoni G; Berti F; Giacomina F; Ponzano S; Pagliuca C; Fiasella A; Pizzirani D; Ortega JA; Nuzzi A; Tarozzo G; Mengatto L; Giampà R; Penna I; Russo D; Romeo E; Summa M; Bertorelli R; Armirotti A; Bertozzi SM; Reggiani A; Bandiera T; Bertozzi F
    J Med Chem; 2021 Sep; 64(18):13327-13355. PubMed ID: 34469137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
    Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
    Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of NAAA Activity.
    Tsuboi K; Ueda N
    Methods Mol Biol; 2023; 2576():261-274. PubMed ID: 36152194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
    Caprioli A; Coccurello R; Rapino C; Di Serio S; Di Tommaso M; Vertechy M; Vacca V; Battista N; Pavone F; Maccarrone M; Borsini F
    J Pharmacol Exp Ther; 2012 Jul; 342(1):188-95. PubMed ID: 22514334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different roles for the acyl chain and the amine leaving group in the substrate selectivity of
    Ghidini A; Scalvini L; Palese F; Lodola A; Mor M; Piomelli D
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1411-1423. PubMed ID: 34256657
    [No Abstract]   [Full Text] [Related]  

  • 30. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
    Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
    Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor.
    Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA
    Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
    Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
    Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
    Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
    ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
    Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
    J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory.
    Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance.
    Congiu M; Micheli L; Santoni M; Sagheddu C; Muntoni AL; Makriyannis A; Malamas MS; Ghelardini C; Di Cesare Mannelli L; Pistis M
    Neurotherapeutics; 2021 Oct; 18(4):2722-2736. PubMed ID: 34553321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.